Literature DB >> 21288845

What is the predominant source of intravascular catheter infections?

Leonard A Mermel1.   

Abstract

The predominant source of intravascular catheter-related bloodstream infections has been a research and clinical question for more than 30 years. During that time, we've moved from the position of a single source predominating in all clinical scenarios to a more realistic appraisal that both skin at the insertion site and the catheter hub/connector (ie, an extraluminal and an intraluminal source of infection, respectively) are important and that maximally effective prevention programs must address both sources of infection.

Entities:  

Mesh:

Year:  2011        PMID: 21288845     DOI: 10.1093/cid/ciq108

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  42 in total

1.  Vascular access sites for acute renal replacement in intensive care units.

Authors:  Audrey E Dugué; Stéphanie P Levesque; Marc-Olivier Fischer; Bertrand Souweine; Jean-Paul Mira; Bruno Megarbane; Cédric Daubin; Damien du Cheyron; Jean-Jacques Parienti
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Intravascular catheter-related bloodstream infection.

Authors:  Harshal Shah; Wendelyn Bosch; Kristine M Thompson; Walter C Hellinger
Journal:  Neurohospitalist       Date:  2013-07

3.  In Vitro and In Vivo Effectiveness of an Innovative Silver-Copper Nanoparticle Coating of Catheters To Prevent Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  Myriam K S Ballo; Sami Rtimi; César Pulgarin; Nancy Hopf; Aurélie Berthet; John Kiwi; Philippe Moreillon; José M Entenza; Alain Bizzini
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

4.  Quasi-experimental study of sodium citrate locks and the risk of acute hemodialysis catheter infection among critically ill patients.

Authors:  Jean-Jacques Parienti; Stéphanie Deryckère; Bruno Mégarbane; Xavier Valette; Amélie Seguin; Bertrand Sauneuf; Jean-Paul Mira; Bertrand Souweine; Vincent Cattoir; Cédric Daubin; Damien du Cheyron
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

5.  Short-Term Peripheral Venous Catheter-Related Bloodstream Infections: Evidence for Increasing Prevalence of Gram-Negative Microorganisms from a 25-Year Prospective Observational Study.

Authors:  Marco Ripa; Laura Morata; Olga Rodríguez-Núñez; Celia Cardozo; Pedro Puerta-Alcalde; Marta Hernández-Meneses; Juan Ambrosioni; Laura Linares; Marta Bodro; Andrea Valcárcel; Climent Casals; Maria de Los Angeles Guerrero-León; Manel Almela; Carolina Garcia-Vidal; Ana Del Río; Francesc Marco; Josep Mensa; José Antonio Martínez; Alex Soriano
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

6.  Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).

Authors:  Silvia Calviño Günther; Carole Schwebel; Rebecca Hamidfar-Roy; Agnès Bonadona; Maxime Lugosi; Claire Ara-Somohano; Clémence Minet; Leïla Potton; Jean-Charles Cartier; Aurelien Vésin; Magalie Chautemps; Lenka Styfalova; Stephane Ruckly; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2016-10-12       Impact factor: 17.440

7.  Effect of silver nanocoatings on catheters for haemodialysis in terms of cell viability, proliferation, morphology and antibacterial activity.

Authors:  F Paladini; M Pollini; D Deponti; A Di Giancamillo; G Peretti; A Sannino
Journal:  J Mater Sci Mater Med       Date:  2013-01-31       Impact factor: 3.896

8.  Molecular investigation of bacterial communities on the inner and outer surfaces of peripheral venous catheters.

Authors:  L Zhang; M Morrison; G R Nimmo; K S Sriprakash; S Mondot; J R Gowardman; N George; N Marsh; C M Rickard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-26       Impact factor: 3.267

9.  Novel Treatment of Staphylococcus aureus Device-Related Infections Using Fibrinolytic Agents.

Authors:  S Hogan; J P O'Gara; E O'Neill
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 10.  A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.

Authors:  Jean-François Timsit; Mark Rupp; Emilio Bouza; Vineet Chopra; Tarja Kärpänen; Kevin Laupland; Thiago Lisboa; Leonard Mermel; Olivier Mimoz; Jean-Jacques Parienti; Garyphalia Poulakou; Bertrand Souweine; Walter Zingg
Journal:  Intensive Care Med       Date:  2018-05-12       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.